Menu
Search icon
  1. Home Page
    2. ›
  2. Counties
    3. ›
  3. New York
    4. ›
  4. 10005
    5. ›
  5. REGENERON PHARMACEUTICALS, INC.

REGENERON PHARMACEUTICALS, INC.

Headquarter
Company claim

Is this your business?

Get access!

Company Details

Name: REGENERON PHARMACEUTICALS, INC.
Jurisdiction: New York
Legal type: DOMESTIC BUSINESS CORPORATION
Status: Active
Date of registration: 11 Jan 1988 (38 years ago)
Entity Number: 1226128
ZIP code: 10005
County: New York
Place of Formation: New York
Address: 28 LIBERTY STREET, NEW YORK, NY, United States, 10005
Principal Address: 777 OLD SAW MILL RIVER ROAD, Tarrytown, NY, United States, 10591

Shares Details

Shares issued 40000000

Share Par Value 0.001

Type PAR VALUE

DOS Process Agent

Name Role Address
REGENERON PHARMACEUTICALS, INC. DOS Process Agent 28 LIBERTY STREET, NEW YORK, NY, United States, 10005

Chief Executive Officer

Name Role Address
LEONARD S. SCHLEIFER, M.D., PH.D. Chief Executive Officer 777 OLD SAW MILL RIVER ROAD, TARRYTOWN, NY, United States, 10591

Agent

Name Role Address
C T CORPORATION SYSTEM Agent 28 LIBERTY ST., NEW YORK, NY, 10005

Links between entities

Type:
Headquarter of
Company Number:
990708
State:
MISSISSIPPI
MISSISSIPPI profile:
REGENERON PHARMACEUTICALS, INC. (MS)
Type:
Headquarter of
Company Number:
10028338
State:
Alaska
Alaska profile:
REGENERON PHARMACEUTICALS, INC. (AK)
Type:
Headquarter of
Company Number:
F11000003622
State:
FLORIDA
FLORIDA profile:
REGENERON PHARMACEUTICALS, INC. (FL)
Type:
Headquarter of
Company Number:
000-019-793
State:
Alabama
Alabama profile:
REGENERON PHARMACEUTICALS, INC. (AL)
Type:
Headquarter of
Company Number:
10f2077d-df0e-e111-aff2-001ec94ffe7f
State:
MINNESOTA
MINNESOTA profile:
REGENERON PHARMACEUTICALS, INC. (MN)
Type:
Headquarter of
Company Number:
0799846
State:
KENTUCKY
KENTUCKY profile:
REGENERON PHARMACEUTICALS, INC. (KY)
Type:
Headquarter of
Company Number:
20111521434
State:
COLORADO
COLORADO profile:
REGENERON PHARMACEUTICALS, INC. (CO)
Type:
Headquarter of
Company Number:
001099964
State:
RHODE ISLAND
RHODE ISLAND profile:
REGENERON PHARMACEUTICALS, INC. (RI)
Type:
Headquarter of
Company Number:
1054405
State:
CONNECTICUT
CONNECTICUT profile:
REGENERON PHARMACEUTICALS, INC. (CT)
Type:
Headquarter of
Company Number:
581087
State:
IDAHO
IDAHO profile:
REGENERON PHARMACEUTICALS, INC. (ID)
Type:
Headquarter of
Company Number:
CORP_68160286
State:
ILLINOIS
ILLINOIS profile:
REGENERON PHARMACEUTICALS, INC. (IL)

Unique Entity ID

Unique Entity ID:
N3F9MH7E6HD6
CAGE Code:
544P9
UEI Expiration Date:
2025-10-16

Business Information

URL:
http://www.regeneron.com
Activation Date:
2024-10-17
Initial Registration Date:
2008-06-18

Central Index Key

CIK number:
0000872589
Phone:
9148477000
EDGAR Link:
View company profile on EDGAR website

Latest Filings

Form type:
8-K
File number:
000-19034
Filing date:
2025-06-18
File:
View File
Form type:
SCHEDULE 13G/A
File number:
005-41938
Filing date:
2025-06-05
File:
View File
Form type:
13F-HR
File number:
028-24826
Filing date:
2025-05-02
File:
View File
Form type:
10-Q
File number:
000-19034
Filing date:
2025-04-29
File:
View File
Form type:
8-K
File number:
000-19034
Filing date:
2025-04-29
File:
View File

Commercial and government entity program

CAGE number:
544P9
Status:
Active
Type:
U.S./Canada Manufacturer
CAGE Update Date:
2024-10-17
CAGE Expiration:
2029-10-17
SAM Expiration:
2025-10-16

Contact Information

POC:
KAELYN BUCK
Corporate URL:
http://www.regeneron.com

Legal Entity Identifier

LEI Number:
549300RCBFWIRX3HYQ56

Registration Details:

Initial Registration Date:
2013-09-10
Next Renewal Date:
2026-01-01
Registration Status:
ISSUED
Validation Source:
FULLY_CORROBORATED

Form 5500 Series

Employer Identification Number (EIN):
133444607
Plan Year:
2013
Number Of Participants:
2247
Sponsors Telephone Number:
9148477400
File:
View File
Plan Year:
2013
Number Of Participants:
2247
Sponsors Telephone Number:
9148477400

History

Start date End date Type Value
2025-06-17 2025-06-17 Address 777 OLD SAW MILL RIVER ROAD, TARRYTOWN, NY, 10591, USA (Type of address: Chief Executive Officer)
2025-06-16 2025-06-16 Shares Share type: PAR VALUE, Number of shares: 320000000, Par value: 0.001
2025-06-16 2025-06-16 Shares Share type: PAR VALUE, Number of shares: 40000000, Par value: 0.001
2025-06-16 2025-06-16 Shares Share type: PAR VALUE, Number of shares: 30000000, Par value: 0.01
2025-05-22 2025-05-22 Shares Share type: PAR VALUE, Number of shares: 30000000, Par value: 0.01

Filings

Filing Number Date Filed Type Effective Date
250617002453 2025-06-16 CERTIFICATE OF AMENDMENT 2025-06-16
240322002328 2024-03-22 BIENNIAL STATEMENT 2024-03-22
220225001293 2022-02-25 BIENNIAL STATEMENT 2022-02-25
200102061097 2020-01-02 BIENNIAL STATEMENT 2020-01-01
SR-16614 2019-01-28 CERTIFICATE OF CHANGE (BY AGENT) 2019-01-28

USAspending Awards / Contracts

Procurement Instrument Identifier:
36C24122N0160
Link:
View Award on USAspending website
Award Or Idv Flag:
AWARD
Award Type:
BPA CALL
Action Obligation:
494095.20
Base And Exercised Options Value:
494095.20
Base And All Options Value:
494095.20
Awarding Agency Name:
Department of Veterans Affairs
Performance Start Date:
2021-11-24
Description:
EVKEEZA DRUG
Naics Code:
325412: PHARMACEUTICAL PREPARATION MANUFACTURING
Product Or Service Code:
6505: DRUGS AND BIOLOGICALS
Procurement Instrument Identifier:
36E79721A0023
Link:
View Award on USAspending website
Award Or Idv Flag:
IDV
Action Obligation:
0.00
Base And All Options Value:
0.00
Awarding Agency Name:
Department of Veterans Affairs
Performance Start Date:
2021-09-30
Description:
EXERCISE OPTION YEAR 3
Naics Code:
325412: PHARMACEUTICAL PREPARATION MANUFACTURING
Product Or Service Code:
6505: DRUGS AND BIOLOGICALS
Procurement Instrument Identifier:
36C24121F0292
Link:
View Award on USAspending website
Award Or Idv Flag:
AWARD
Award Type:
DELIVERY ORDER
Action Obligation:
148228.56
Base And Exercised Options Value:
148228.56
Base And All Options Value:
148228.56
Awarding Agency Name:
Department of Veterans Affairs
Performance Start Date:
2021-09-08
Description:
EVKEEZA
Naics Code:
325412: PHARMACEUTICAL PREPARATION MANUFACTURING
Product Or Service Code:
6505: DRUGS AND BIOLOGICALS

USAspending Awards / Financial Assistance

Date:
2009-09-29
Link:
View on USAspending
Awarding Agency Name:
Department of Health and Human Services
Transaction Description:
PRODUCTION OF TARGETED NULL MUTATIONS FOR 10,000 GENES IN C57BL/6 ES CELLS
Obligated Amount:
14862829.00
Face Value Of Loan:
0.00
Total Face Value Of Loan:
0.00

Trademarks Section

Serial Number:
99255257
Status:
NEW APPLICATION - RECORD INITIALIZED NOT ASSIGNED TO EXAMINER
Mark Type:
TRADEMARK
Application Filing Date:
2025-06-26
USPTO Link:
View Trademark Status and Document Retrieval (TSDR)

Goods And Services

For:
Pharmaceutical preparations for the treatment of auditory and neurological diseases and disorders; Pharmaceutical preparations for gene therapy for the treatment of auditory and neurological diseases and disorders
International Classes:
005 - Primary Class
Class Status:
Active
Serial Number:
99199652
Mark:
REGENERON
Status:
NEW APPLICATION - RECORD INITIALIZED NOT ASSIGNED TO EXAMINER
Mark Type:
TRADEMARK
Application Filing Date:
2025-05-23
Mark Drawing Type:
Standard character mark
Mark Literal Elements:
REGENERON
USPTO Link:
View Trademark Status and Document Retrieval (TSDR)

Goods And Services

For:
Pharmaceutical preparations and substances for the treatment and/or prevention of diseases, namely, genetic diseases, diseases of the immune system, infectious diseases, autoimmune diseases, and cancer; genetically modified cells, genome editing reagents, and biological preparations, namely, viral v...
International Classes:
005 - Primary Class
Class Status:
Active
Serial Number:
99184546
Mark:
REGENERON
Status:
NEW APPLICATION - RECORD INITIALIZED NOT ASSIGNED TO EXAMINER
Mark Type:
TRADEMARK
Application Filing Date:
2025-05-14
Mark Drawing Type:
Standard character mark
Mark Literal Elements:
REGENERON
USPTO Link:
View Trademark Status and Document Retrieval (TSDR)

Goods And Services

For:
Pharmaceutical preparations for the treatment of auditory and neurological diseases and disorders; Pharmaceutical preparations for gene therapy for the treatment of auditory and neurological diseases and disorders
International Classes:
005 - Primary Class
Class Status:
Active
Serial Number:
98007901
Mark:
GR8 EYE MOVEMENT
Status:
NOTICE OF ALLOWANCE - ISSUED
Mark Type:
SERVICE MARK
Application Filing Date:
2023-05-22
Mark Drawing Type:
Standard character mark
Mark Literal Elements:
GR8 EYE MOVEMENT
USPTO Link:
View Trademark Status and Document Retrieval (TSDR)

Goods And Services

For:
Providing information in the field of vision assessment and eye diseases and disorders
International Classes:
044 - Primary Class
Class Status:
Active
Serial Number:
98007892
Mark:
GREAT EYE MOVEMENT
Status:
ABANDONED - NO STATEMENT OF USE FILED
Mark Type:
SERVICE MARK
Application Filing Date:
2023-05-22
Mark Drawing Type:
Standard character mark
Mark Literal Elements:
GREAT EYE MOVEMENT
USPTO Link:
View Trademark Status and Document Retrieval (TSDR)

Goods And Services

For:
Providing information in the field of vision assessment and eye diseases and disorders
International Classes:
044 - Primary Class
Class Status:
Active

OSHA's Inspections within Industry

Inspection Summary

Date:
2009-09-03
Type:
Complaint
Address:
81 COLUMBIA TURNPIKE, RENSSELAER, NY, 12144
Safety Health:
Health
Scope:
Partial
Inspection Link:
View Inspection data on OSHA website

Inspection Summary

Date:
2009-09-03
Type:
Complaint
Address:
81 COLUMBIA TURNPIKE, RENSSELAER, NY, 12144
Safety Health:
Safety
Scope:
Partial
Inspection Link:
View Inspection data on OSHA website

Inspection Summary

Date:
2007-10-04
Type:
Prog Other
Address:
81 COLUMBIA TURNPIKE, RENSSELAER, NY, 12144
Safety Health:
Safety
Scope:
Partial
Inspection Link:
View Inspection data on OSHA website

Motor Carrier Census

Carrier Operation:
Interstate
Phone:
(914) 847-7466
Email:
ELIZABETH.GREEN@REGENERON.COM
Add Date:
2015-07-13
Operation Classification:
Private(Property)
power Units:
8
Drivers:
58
Inspections:
0
FMCSA Link:
View on FMCSA website

Court Cases

Court Case Summary

Filing Date:
2024-12-30
Status:
Terminated
Nature Of Judgment:
no monetary award
Jury Demand:
Both plaintiff and defendant demand jury
Nature Of Suit:
Patent

Parties

Party Name:
ALLELE BIOTECHNOLOGY AND PHARM
Party Role:
Plaintiff
Party Name:
REGENERON PHARMACEUTICALS, INC.
Party Role:
Defendant

Court Case Summary

Filing Date:
2024-12-09
Status:
Pending
Nature Of Judgment:
Missing
Jury Demand:
Plaintiff demands jury
Nature Of Suit:
Antitrust

Parties

Party Name:
REGENERON PHARMACEUTICALS, INC.
Party Role:
Plaintiff
Party Name:
NOVARTIS PHARMA AG,
Party Role:
Defendant

Court Case Summary

Filing Date:
2024-04-08
Status:
Terminated
Nature Of Judgment:
no monetary award
Jury Demand:
Both plaintiff and defendant demand jury
Nature Of Suit:
Antitrust

Parties

Party Name:
REGENERON PHARMACEUTICALS, INC.
Party Role:
Plaintiff
Party Name:
NOVARTIS PHARMA AG,
Party Role:
Defendant

Reviews Leave a review

This company hasn't received any reviews.

Related by officers

C T CORPORATION SYSTEM

BOFA MERRILL LYNCH ASSET HOLDINGS, INC. " 21" BRANDS, INC. "ADP TOTALSOURCE SERVICES, INC." ARLON GROUP LLC "LA COMUNIDAD" CORPORATION "TREND LABORATORIES, INC." (800) 777-CLUB. ++INTEGRATED TACTICS, LLC +42 W 35TH HOLDINGS LLC

Related by address

28 LIBERTY STREET, NEW YORK, NY, United States, 10005

+42 W 35TH HOLDINGS LLC 0511 BLUM CHARLTON, LLC 1 BAY BLVD HOLDINGS, LLC 1 DANIEL LORD ROAD LLC 1 DEARBORN TACOS LLC 1 HOTEL BROOKLYN BRIDGE, L.L.C. 1 HOTEL CENTRAL PARK, L.L.C. 1 KAKIAT COURT LLC 1 MILL ROAD APARTMENTS INVESTORS RHPI, LLC 1 RAYMOND ST LLC

Date of last update: 16 Mar 2025

Sources: New York Secretary of State

Privacy policy Policy
About us About us
Contacts Contact us

© 2025 bizyork.com, Part of Big Data Integrated